These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3945245

  • 21. [Comparative study of urinary calcium, oxalate and uric acid in calcium oxalate lithiasis].
    Dumoulin G, Haton D, Wolf JP, Henriet MT, Nguyen NU, Mougin C, Saint-Hillier Y, Combes M, Berthelay S.
    Nephrologie; 1984; 5(5):189-91. PubMed ID: 6531054
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Evidence of a link between erythrocyte band 3 phosphorylation and anion transport in patients with 'idiopathic' calcium oxalate nephrolithiasis.
    Baggio B, Bordin L, Gambaro G, Piccoli A, Marzaro G, Clari G.
    Miner Electrolyte Metab; 1993; 19(1):17-20. PubMed ID: 8393959
    [Abstract] [Full Text] [Related]

  • 26. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P, Portmann L, Jacquet AF, Burckhardt P.
    Schweiz Med Wochenschr; 1986 Dec 13; 116(50):1783-6. PubMed ID: 3798070
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The relationship of 3' vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis.
    Mossetti G, Rendina D, Viceconti R, Manno G, Guadagno V, Strazzullo P, Nunziata V.
    Nephrol Dial Transplant; 2004 Sep 13; 19(9):2259-65. PubMed ID: 15213319
    [Abstract] [Full Text] [Related]

  • 30. [Diurnal variation in plasma oxalate concentration and oxalate clearance in calcium oxalate stone formers with special reference to the effect of oxalate loading].
    Kinoshita N.
    Hinyokika Kiyo; 1987 Sep 13; 33(9):1331-41. PubMed ID: 3434488
    [Abstract] [Full Text] [Related]

  • 31. Role of cellular oxalate in oxalate clearance of patients with calcium oxalate monohydrate stone formation and normal controls.
    Oehlschläger S, Fuessel S, Meye A, Herrmann J, Froehner M, Albrecht S, Wirth MP.
    Urology; 2009 Mar 13; 73(3):480-3. PubMed ID: 19167040
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Responsiveness of hypercalciuria to thiazide in Dent's disease.
    Raja KA, Schurman S, D'mello RG, Blowey D, Goodyer P, Van Why S, Ploutz-Snyder RJ, Asplin J, Scheinman SJ.
    J Am Soc Nephrol; 2002 Dec 13; 13(12):2938-44. PubMed ID: 12444212
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Urinary excretion of oxalate by patients with renal hypercalciuric stone disease. Effect of chronic treatment with hydrochlorothiazide.
    Urivetzky M, Braverman S, Motola JA, Smith AD.
    Urology; 1991 Apr 13; 37(4):327-30. PubMed ID: 2014597
    [Abstract] [Full Text] [Related]

  • 40. The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment.
    Peña JC, Monforte MF, Briceño A.
    J Urol; 1987 Nov 13; 138(5):1137-40. PubMed ID: 3669156
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.